Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-10

Clinical Trial Update: Pancreatoduodenectomy With Mesopancreas Dissection.A Prospective Study Comparing Artery-first Approach Versus Standard Approach [NA]

View source ↗

Summary

A prospective study comparing artery-first versus standard mesopancreas dissection during pancreatoduodenectomy for resectable periampullary carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Periampullary Carcinoma Resectable | NA | Status: UNKNOWN